Volker Knappertz
Equibles does not estimate personal net worth.
About Volker Knappertz
The proxy statement of Aurinia Pharmaceuticals Inc. reports total compensation of $3,436,474 for Volker Knappertz in fiscal 2023, including a base salary of $516,250. Disclosed compensation is on record for 4 fiscal years.
Affiliation history
-
Aurinia Pharmaceuticals Inc. (AUPH)
Proxy statement
Start not stated–2024-05-03
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Aurinia Pharmaceuticals Inc. (AUPH) | EVP, Research and Development | $516,250 | $3,436,474 |
| 2022 | Aurinia Pharmaceuticals Inc. (AUPH) | EVP, Research and Development | $229,167 | $2,983,686 |
| 2021 | Aurinia Pharmaceuticals Inc. (AUPH) | EVP, Research and Development | — | — |
| 2020 | Aurinia Pharmaceuticals Inc. (AUPH) | EVP, Research and Development | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.